Sino Biopharmaceutical (HKSE:01177) EV-to-Revenue : 1.71 (As of May. 01, 2024)

View and export this data going back to 2003. Start your Free Trial

What is Sino Biopharmaceutical EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sino Biopharmaceutical's enterprise value is HK$49,075 Mil. Sino Biopharmaceutical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$28,656 Mil. Therefore, Sino Biopharmaceutical's EV-to-Revenue for today is 1.71.

The historical rank and industry rank for Sino Biopharmaceutical's EV-to-Revenue or its related term are showing as below:

HKSE:01177' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.75 Med: 3.21 Max: 7.98
Current: 1.71

During the past 13 years, the highest EV-to-Revenue of Sino Biopharmaceutical was 7.98. The lowest was 1.75. And the median was 3.21.

HKSE:01177's EV-to-Revenue is ranked better than
80.8% of 1031 companies
in the Biotechnology industry
Industry Median: 7.91 vs HKSE:01177: 1.71

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-01), Sino Biopharmaceutical's stock price is HK$2.70. Sino Biopharmaceutical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.54. Therefore, Sino Biopharmaceutical's PS Ratio for today is 1.75.

Sino Biopharmaceutical EV-to-Revenue Historical Data

The historical data trend for Sino Biopharmaceutical's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical EV-to-Revenue Chart

Sino Biopharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

4.89

5.23

3.27

3.16

2.51

Sino Biopharmaceutical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															3.27	-	3.16	-	2.51

Competitive Comparison of Sino Biopharmaceutical's EV-to-Revenue

For the Biotechnology subindustry, Sino Biopharmaceutical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sino Biopharmaceutical's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sino Biopharmaceutical's EV-to-Revenue falls into.

Sino Biopharmaceutical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sino Biopharmaceutical's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	49074.646	/	28656.386
	=	1.71

Sino Biopharmaceutical's current Enterprise Value is HK$49,075 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sino Biopharmaceutical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$28,656 Mil.

Sino Biopharmaceutical (HKSE:01177) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sino Biopharmaceutical's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	2.70	/	1.543
	=	1.75

Sino Biopharmaceutical's share price for today is HK$2.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.54.

Sino Biopharmaceutical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biopharmaceutical (HKSE:01177) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (HKSE:01177) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

SBHMY:USA SBMFF:USA SMZ1:Germany

Address

1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG

Website

https://www.sinobiopharm.com

Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.

Sino Biopharmaceutical (HKSE:01177) Headlines

No Headlines